Muscle relaxants for pain management in rheumatoid arthritis.
CONCLUSIONS: Based upon the currently available evidence in patients with RA, benzodiazepines (diazepam and triazolam) do not appear to be beneficial in improving pain over 24 hours or one week. The non-benzodiazepine agent zopiclone also did not significantly reduce pain over two weeks. However, even short term muscle relaxant use (24 hours to 2 weeks) is associated with significant adverse events, predominantly drowsiness and dizziness. PMID: 22258993 [PubMed - in process] (Source: Cochrane Database of Systematic Reviews)

FDA Safety Changes: Valium, Noxafil, Strattera
The FDA has approved revisions to the safety labeling for diazepam tablets (Valium), posaconazole oral suspension (Noxafil), and atomoxetine HCl capsules (Strattera). Medscape Medical News (Source: Medscape Medical News Headlines)